ENVESTNET ASSET MANAGEMENT INC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$345,669
-50.0%
41,348
+48.6%
0.00%
Q2 2023$691,098
+189.9%
27,822
+75.5%
0.00%
Q1 2023$238,369
+92.7%
15,849
+51.6%
0.00%
Q4 2022$123,683
-56.6%
10,455
+21.9%
0.00%
Q3 2021$285,000
-40.9%
8,574
-31.0%
0.00%
Q2 2021$482,000
-8.4%
12,421
+13.9%
0.00%
Q1 2021$526,000
+49.9%
10,908
+61.5%
0.00%
Q4 2020$351,0006,7540.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders